Загрузка...
Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity
The 2019 coronavirus disease (COVID-19), caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed serious threats to global public health and economic and social stabilities, calling for the prompt development of therapeutics and prophylactics. In this study, we...
Сохранить в:
| Опубликовано в: : | J Virol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7343218/ https://ncbi.nlm.nih.gov/pubmed/32376627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00635-20 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|